baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AVEO Pharmaceuticals/ US0535883070 /

2023-01-19 9:59:43 PM	Chg. -	Volume	Bid-	Ask-	High	Low
15.00USD	-	3,055 Turnover: 45,820	-Bid Size: -	-Ask Size: -	15.00	14.99

GlobeNewswire 03-28 CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientif...

GlobeNewswire 03-25 AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Co...

GlobeNewswire 02-06 AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advan...

GlobeNewswire 01-16 AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in ...

GlobeNewswire 2022-03-07 AVEO Oncology to Announce Full Year 2021 Financial Results and Host Conference Call and Webcast on M...

GlobeNewswire 2022-02-14 AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivo...

GlobeNewswire 2022-02-03 AVEO Oncology Announces Participation at the 11th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire 2022-01-20 AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Ca...

GlobeNewswire 2022-01-04 AVEO Oncology Highlights Recent Progress and 2022 Outlook

GlobeNewswire 2021-12-22 AVEO Oncology Announces Participation at the H.C. Wainwright Virtual BioConnect 2022 Conference

GlobeNewswire 2021-12-20 Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer

GlobeNewswire 2020-11-02 Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders

GlobeNewswire 2019-12-12 Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

GlobeNewswire 2019-11-05 CORRECTING and REPLACING -- XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and F...

GlobeNewswire 2019-11-05 XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results

GlobeNewswire 2019-08-28 Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer

GlobeNewswire 2019-08-28 Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer

GlobeNewswire 2019-04-30 Global Chronic Kidney Disease Markets and Technologies Through 2023

GlobeNewswire 2019-04-26 APRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed ...

GlobeNewswire 2019-04-25 CLASS ACTION UPDATE for CORT, AVEO, NIO and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class A...

GlobeNewswire 2019-04-25 FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pha...

GlobeNewswire 2019-04-24 AVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important...

GlobeNewswire 2019-04-23 Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 2019-04-19 SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important...

GlobeNewswire 2019-04-18 APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pha...

AVEO Pharmaceuticals/ US0535883070 /

If you wish to receive reply to your feedback, please provide your email address.